Navigation Links
ACC/HRS release appropriate use criteria for ICDs and CRT
Date:2/28/2013

WASHINGTON (Feb. 28, 2013) The American College of Cardiology and the Heart Rhythm Society, along with key specialty societies, today released appropriate use criteria for implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT). The document provides assessed levels of appropriateness for implanting the devices in 369 real-life clinical scenarios, with the goal of enhancing physician and patient decision making and improving care and health outcomes.

Implantable cardioverter-defibrillators are devices that monitor the heart's rhythms and correct arrhythmias (abnormal heartbeats) by providing electrical pulses to the heart. By immediately responding to any abnormal rhythm, ICDs help prevent sudden cardiac death. Cardiac resynchronization therapy uses an implantable device to synchronize the beating of the heart's left and right ventricles. This improves the heart's efficiency and reduces its stress. While both ICDs and CRT have expanded treatment options for cardiac patients, the ACC and HRS examined their use as part of an ongoing effort to critically and systematically review the diagnostic tests and procedures involved in cardiovascular care.

The criteria focus on scenarios that were derived from physician experience, clinical practice guidelines, and results of studies examining device implantation. The scenarios identify "real life" clinical situations encountered in daily practice. These clinical presentations include patients that may not be specifically covered by clinical guidelines, which the organizations hope will provide valuable assistance for decision making by physicians and patients.

"The goal of this document is to help inform medical decisions and assist clinicians and stakeholders in understanding areas of both consensus and uncertainty, while identifying areas where there are gaps in knowledge that warrant further research," noted Dr. Andrea M. Russo, writing committee co-chair and Director of Electrophysiology and Arrhythmia Services at Cooper University Hospital.

The scenarios cover six areas: ICDs for secondary prevention, ICDs for primary prevention, comorbidities, CRT devices, generator replacement, and dual- versus single-chamber ICDs.

A 10-member writing committee drafted the scenarios, while a separate technical panel rated each on a numerical scale as "Appropriate" (median 7 to 9), "May Be Appropriate" (median 4 to 6), or "Rarely Appropriate" (median 1 to 3). Of the 369 scenarios, 45% were deemed Appropriate, 33% were rated May Be Appropriate, and 22% were determined Rarely Appropriate. The writing committee stated that the appropriate use criteria can help inform the decision making process but should not be used as a substitute for careful clinical judgment and clinical practice experience nor current coverage and reimbursement policies.

"The decision to implant an ICD or CRT device is often complex, based on clinical evidence and clinical judgment, while taking into account comorbidities and other individual patient factors," said Russo. "While this document was designed to help inform clinical decision making, it does not establish 'rules' by which decisions should be made in clinical practice. Healthcare providers and other stakeholders should continue to acknowledge the pivotal role of clinical judgment in determining whether device implantation is indicated for an individual patient."

Russo added that the appropriate use criteria "can also be used to create algorithms or educational tools that help identify resource utilization or variations in care." These tools can be used at the point of caresuch as hospitals or physician officeswhere utilization decisions are made. Data generated from these tools or collected in registries can be used to identify the patient mix for these procedures for individual institutions. This information can then be used for benchmarking over time and for comparison to other organizations.


'/>"/>

Contact: Rachel Cagan
rcagan@acc.org
202-375-6395
American College of Cardiology
Source:Eurekalert

Related medicine news :

1. Internal medicine physician specialists release policy paper on reforming Medicaid
2. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
3. Soybeans soaked in warm water naturally release key cancer-fighting substance
4. Markle releases new resources for health information sharing implementation
5. ASCO releases studies from upcoming annual meeting
6. Landmark textbook on health care and the US legal system released
7. Data release from the Allen Institute for Brain Science expands online atlas offerings
8. Boys Town Releases 5 Signs of Heat Stroke in Kids
9. Metabolic Cooking Review For Karine Losier and Dave Ruel's Diet And Cookbook Program Released
10. Waterpik Water Flosser Reviews Released Today By WaterpikReviews.net
11. GMC Denali Road Bike Review Released Today By GMCDenaliRoadBike.net
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: